BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| bifidobacterium bifidum {B. bifidum} - Escherichia coli 6-319-05_S3_C3 |
👶
Efficacy of oral Bifidobacterium bifidum ATCC 29521 on microflora and antioxidant in mice. Canadian journal of microbiology (Can J Microbiol ) Vol: 62 Issue 3 Pages: 249-62 Pub: 2016 Mar Epub: 2015 Dec 15 Authors Wang BG , Xu HB , Xu F , Zeng ZL , Wei H , Publication |
| bifidobacterium bifidum {B. bifidum} - Escherichia coli 6-319-05_S3_C3 |
👶
Growth assessment of mixed cultures of probiotics and common pathogens. Anaerobe (Anaerobe ) Vol: Issue Pages: 102790 Pub: 2023 Oct 28 Epub: 2023 Oct 28 Authors Fredua-Agyeman M , Stapleton P , Gaisford S , Publication |
| bifidobacterium bifidum {B. bifidum} - Escherichia coli 6-319-05_S3_C3 |
👶
Dietary Mannan-oligosaccharides potentiate the beneficial effects of Bifidobacterium bifidum in broiler chicken. Letters in applied microbiology (Lett Appl Microbiol ) Vol: 71 Issue 5 Pages: 520-530 Pub: 2020 Nov Epub: 2020 Aug 24 Authors Dev K , Akbar Mir N , Biswas A , Kannoujia J , Begum J , Kant R , Publication |
| bifidobacterium bifidum {B. bifidum} - Escherichia coli 6-319-05_S3_C3 |
👶
Nature of the antimicrobial activity of Lactobacillus casei, Bifidobacterium bifidum and Bifidobacterium animalis against foodborne pathogenic and spoilage microorganisms. Natural product research (Nat Prod Res ) Vol: 29 Issue 22 Pages: 2133-6 Pub: 2015 Epub: 2014 Dec 23 Authors de Oliveira CP , da Silva JA , de Siqueira-Júnior JP , Publication |
| bifidobacterium bifidum {B. bifidum} - Escherichia coli 6-319-05_S3_C3 |
👶
Cytotoxicity assessment and antimicrobial effects of cell-free supernatants from probiotic lactic acid bacteria and yeast against multi-drug resistant Escherichia coli. Letters in applied microbiology (Lett Appl Microbiol ) Vol: 77 Issue 9 Pages: Pub: 2024 Sep 2 Epub: Authors Ozma MA , Ghotaslou R , Asgharzadeh M , Abbasi A , Rezaee MA , Kafil HS , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
